These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23417729)

  • 1. Endocrine disruptors and the breast: early life effects and later life disease.
    Macon MB; Fenton SE
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):43-61. PubMed ID: 23417729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating chemical effects on mammary gland development: A critical need in disease prevention.
    Osborne G; Rudel R; Schwarzman M
    Reprod Toxicol; 2015 Jul; 54():148-55. PubMed ID: 25091782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.
    Teitelbaum SL; Belpoggi F; Reinlib L
    Reprod Toxicol; 2015 Jul; 54():141-7. PubMed ID: 25549947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
    Hilakivi-Clarke L; de Assis S; Warri A
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):25-42. PubMed ID: 23392570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
    Fenton SE
    Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine disruption of the epigenome: a breast cancer link.
    Knower KC; To SQ; Leung YK; Ho SM; Clyne CD
    Endocr Relat Cancer; 2014 Apr; 21(2):T33-55. PubMed ID: 24532474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional modulation of terminal end buds: its relevance to breast cancer prevention.
    Hilakivi-Clarke L
    Curr Cancer Drug Targets; 2007 Aug; 7(5):465-74. PubMed ID: 17691906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixtures of environmentally relevant endocrine disrupting chemicals affect mammary gland development in female and male rats.
    Mandrup KR; Johansson HK; Boberg J; Pedersen AS; Mortensen MS; Jørgensen JS; Vinggaard AM; Hass U
    Reprod Toxicol; 2015 Jul; 54():47-57. PubMed ID: 25305543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposures, breast development and cancer risk: Through the looking glass of breast cancer prevention.
    Forman MR; Winn DM; Collman GW; Rizzo J; Birnbaum LS
    Reprod Toxicol; 2015 Jul; 54():6-10. PubMed ID: 25499721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine disrupting chemicals and the mammary gland.
    Vandenberg LN
    Adv Pharmacol; 2021; 92():237-277. PubMed ID: 34452688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine-active chemicals in mammary cancer causation and prevention.
    Jenkins S; Betancourt AM; Wang J; Lamartiniere CA
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.
    Soto AM; Brisken C; Schaeberle C; Sonnenschein C
    J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):199-208. PubMed ID: 23702822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
    Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
    Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine-Disrupting Chemicals and Their Effects during Female Puberty: A Review of Current Evidence.
    Lucaccioni L; Trevisani V; Marrozzini L; Bertoncelli N; Predieri B; Lugli L; Berardi A; Iughetti L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.
    Rudel RA; Fenton SE; Ackerman JM; Euling SY; Makris SL
    Environ Health Perspect; 2011 Aug; 119(8):1053-61. PubMed ID: 21697028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Environmental Exposures as a Critical Element in Breast Cancer Risk.
    Fenton SE; Birnbaum LS
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3245-50. PubMed ID: 26214118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A special issue dedicated to a complex tissue.
    Fenton SE
    Reprod Toxicol; 2015 Jul; 54():1-5. PubMed ID: 25986312
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast and prostate glands affected by environmental substances (Review).
    Bleak TC; Calaf GM
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disrupting chemicals and disease susceptibility.
    Schug TT; Janesick A; Blumberg B; Heindel JJ
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mitochondrial metabolism and mammary carcinogenesis.
    Yadava N; Schneider SS; Jerry DJ; Kim C
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):75-87. PubMed ID: 23269521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.